Uterine Contractility as a Quantitative Endpoint in Early-Phase Gynaecology Trials

Uterine Contractility as a Quantitative Endpoint in Early-Phase Gynaecology Trials

Establishing uterine contractility as a quantitative, reproducible imaging endpoint for early-phase gynaecology trials.

icon Oncology
Motility & MovementMRIExploratory
In this case study
    Study details
    PublishedJanuary 2025
    Therapy AreasOncology
    Endpoint typeMotility & Movement
    ModalityMRI
    Study phaseExploratory
    01 — Situation

    The scientific question behind the program.

    This case study outlines an early-phase imaging challenge and the endpoint strategy Fidēs designed to answer the biological question at hand. Replace this with the program-specific narrative.

    02 — Our Approach

    Designing imaging endpoints around the biology.

    Fidēs aligned the imaging strategy with the study’s decision points, implementing quantitative measures appropriate to the indication and modality.

    03 — Impact

    Clearer, earlier decisions.

    The approach delivered a richer, more sensitive read-out to support the go / no-go decision. Replace with the measured outcome.

    More From Fidēs

    Other case studies

    icon Gastroenterology
    The Role of Movement in Characterising Treatment Response in IBD

    Augmenting standard MRI endpoints with motility measures to deliver a more complete characterisation of biological response in Crohn's disease.

    Read case study
    icon Gastroenterology
    The Power of Movement: Motion as an Imaging Endpoint

    Augmenting standard MRI endpoints with motility measures to deliver a more complete characterisation of biological response in Crohn's disease.

    Read case study
    icon Gastroenterology
    Structural and Functional MRI Assessment in Post-Surgical J-Pouch Patients

    Combining structural and functional MRI to characterise pouch function and inflammation in post-surgical J-pouch patients.

    Read case study
    icon Oncology
    Beyond RECIST: Additive Imaging Endpoints in Solid Tumour Trials

    How augmented endpoint analysis provides earlier and more interpretable signals than standard volumetric measures alone.

    Read case study
    icon Oncology
    Live Data Visibility in Phase I Imaging Trials

    A review of how real-time imaging access changes sponsor behaviour and supports earlier go / no-go decisions in early development.

    Read case study
    icon Gastroenterology
    Augmented MRI Endpoints in a Phase II Crohn’s Program

    Adding functional motility metrics to a Phase II Crohn's imaging protocol to sharpen the read on treatment response.

    Read case study
    icon Gastroenterology
    Cine-MRI Motility Analysis as a Primary Endpoint

    Using cine-MRI motility analysis as a primary endpoint to detect functional change earlier than structural measures alone.

    Read case study
    Work With Us

    Ready to discuss
    your study?

    Whether you are early in study design or scoping an imaging partner for an upcoming trial, we are happy to have a no-obligation conversation about your program.

    Get in Touch Get in Touch